This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
il-23
IL-23
IL-23 is a heterodimeric cytokine (IL-23p19/p40) produced by DCs and macrophages; IL-23 → IL-23R/JAK1/TYK2/STAT3 → Th17 cell maintenance and IL-17 production; IL-23 drives psoriasis and IBD; anti-IL-23p19 antibodies (risankizumab, guselkumab) are first-line biologics.
Entry Metadata
| Field | Value |
|---|---|
| ID | il-23 |
| Name | IL-23 |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715-725. · PubMed 11057895
- Gordon KB, Strober B, Lebwohl M, et al. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2). Lancet. 2018;392(10148):650-661. · PubMed 30097359